论文部分内容阅读
胃癌首选的治疗手段是手术切除,但由于胃癌一般起病隐匿,症状不典型,其早期诊断率较低,在确诊时,约50%的胃癌患者肿瘤已无法切除,发生局部进展或转移,丧失了手术切除机会。晚期及复发性胃癌对化疗相对敏感,[1]由于胃癌对化疗相对敏感,全身化疗是晚期及复发性胃癌主要治疗手段之一。但迄今为止,晚期胃癌仍缺乏所谓的“金标准”化疗方案,如何合理的联合应用化疗药物,使其发挥最大疗效并尽可能减少其不良反应是目前研究的热点。2011年3月~2013年3月对就诊于我院的晚期胃癌患者320例应用替吉奥联合奥沙利铂治疗并取得良好疗效,现报告如下。
The preferred treatment of gastric cancer is surgical resection, but because of the general onset of occult gastric cancer, atypical symptoms, the early diagnosis rate is low, at the time of diagnosis, about 50% of gastric cancer patients have been unresectable, the occurrence of local progression or metastasis, loss Surgical removal opportunities. Advanced and recurrent gastric cancer is relatively sensitive to chemotherapy, [1] because of gastric cancer is relatively sensitive to chemotherapy, systemic chemotherapy is one of the main treatment of advanced and recurrent gastric cancer. However, up to now, advanced gastric cancer still lacks the so-called “gold standard” chemotherapy regimen. How to combine chemotherapeutics rationally to maximize its efficacy and minimize its adverse reactions is a hot topic at present. From March 2011 to March 2013, 320 patients with advanced gastric cancer who were treated in our hospital were treated with tioguanxue combined with oxaliplatin and achieved good results. The report is as follows.